/**/ document.writeln("\n\n \n
\n \n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n \n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n\n \n \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n \n \n \n \n \n \n\n\n\n\n\n\n\n \n \n \n \n\n\n\n
\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n
QuoteChartsNewsFilingsHistorical
\n \n\n
\n \n
Profile ·  Share Information ·  Key Ratios
\n
\n\n\n\n\n\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n\n\n \n\n\n\n\n\n\n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n
Profile for Allon Therapeutics Inc.\n\n  (T.NPC) \n\n \n\n \n\n
\n\n\n\n
\n\n \n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n $ 0.32\n\n \n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n \n\n \n\n  \n\n 0.01\n\n (+3.23%)\n\n \n\n \n\n \n\n \n\n Volume: 0\n\n \n\n \n\n\n\n 3:17 PM EST Nov 20, 2009\n\n\n\n \n\n
\n\n\n\n\n\n\n\n
\n\n
\n\n \n\n \n\n \n\n \n\n\n \n \n \n \n \n \n \n\n \n\n \n\n
\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n
Business Description:
\n\n A Canadian biotechnology company developing drugs that protect against neurodegenerative conditions such as Alzheimer's disease, mild cognitive impairment and schizophrenia-relatedcognitive impairment.\n\n
Address:1168 Hamilton Street, Suite 506, Vancouver, BC, CA V6B 2S2
Telephone:(604) 736-0634Website:www.allontherapeutics.com
Facsimile:(604) 736-1616Email:akeay@allontherapeutics.com
\n\n \n\n \n\n
\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n
Details
CEO:Gordon C. McCauley
Employees:18MarketCap:24.98 m
Issue Type:CS
Auditor:KPMG LLP
Last Audit:UQ
Indices:\n\n \n\n Biotechnology\n\n \n\n
\n\n
\n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n
Industry Classifications
Sector:\n\n \n\n Healthcare\n\n \n\n CIK: 
Industry:\n\n \n\n Drugs\n\n \n\n
Sub-Industry:   \n\n \n\n Biotechnology\n\n \n\n
NAICS:\n\n \n\n Pharmaceutical and Medicine Manufacturing (325410)\n\n \n\n
SIC:\n\n \n\n Pharmaceutical and Medicine Industry (3741)\n\n \n\n
\n\n
\n\n
\n\n\n\n\n \n \n \n\n \n \n \n \n
\n
\n \n \n\n
\n\n\n
Copyright © QuoteMedia.  \n\n\n Data delayed 15 minutes unless otherwise indicated (View delay times for all exchanges).  \n RT   Realtime, \n\n DL+   Realtime BATS,  \n\n EOD   End Of Day,  \n\n PD   Previous Day.  \n\n\n Market Data powered by QuoteMedia, profiles by Morningstar.  Terms of Use. 
\n
 
\n\n
\n \n
\n
\n");